LaSalle Street Capital Management’s Charles River Laboratories CRL Stock Holding History

LaSalle Street Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$211K	Hold	1,592	–	–	0.24%	85
2019 Q2	$226K	Hold	1,592	–	–	0.26%	83
2019 Q1	$231K	Sell	1,592 -1,130	-42%	-$148K	0.27%	84
2018 Q4	$308K	Sell	2,722 -1,367	-33%	-$171K	0.44%	71
2018 Q3	$550K	Sell	4,089 -26	-0.6%	-$3.21K	0.64%	55
2018 Q2	$462K	Sell	4,115 -1,824	-31%	-$197K	0.46%	67
2018 Q1	$634K	Sell	5,939 -274	-4%	-$29.5K	0.5%	67
2017 Q4	$680K	Buy	6,213 +894	+17%	+$97.3K	0.47%	65
2017 Q3	$575K	Buy	5,319 +944	+22%	+$97K	0.42%	66
2017 Q2	$443K	Hold	4,375	–	–	0.36%	62
2017 Q1	$394K	Hold	4,375	–	–	0.33%	65
2016 Q4	$333K	Buy	4,375 +1,763	+67%	+$134K	0.3%	65
2016 Q3	$218K	Hold	2,612	–	–	0.2%	82
2016 Q2	$215K	Buy	+2,612	New	+$215K	0.21%	80
2016 Q1	–	Sell	-2,644	Closed	-$213K	–	84
2015 Q4	$213K	Buy	+2,644	New	+$191K	0.21%	76

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LaSalle Street Capital Management's CRL Position: Q3 2019 in Review

LaSalle Street Capital Management held its Charles River Laboratories (CRL) position steady in Q3 2019 at 1,592 shares worth $211K. The position accounts for 0.24% of the portfolio, ranked #85.

LaSalle Street Capital Management first reported a position in CRL in Q4 2015 and has held it in 15 quarters since. The position peaked at $680K in Q4 2017. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

LaSalle Street Capital Management held 1,592 shares of Charles River Laboratories worth $211K as of Q3 2019.
LaSalle Street Capital Management left its Charles River Laboratories share count unchanged in Q3 2019.
Charles River Laboratories made up 0.24% of LaSalle Street Capital Management's portfolio in Q3 2019, its #85 holding.
LaSalle Street Capital Management first reported a position in Charles River Laboratories in Q4 2015 and has held it in 15 quarters since.
LaSalle Street Capital Management's Charles River Laboratories position peaked at $680K in Q4 2017.
396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on LaSalle Street Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.